Matrix Metalloproteinases (MMP), a Major Responsible Downstream Signaling Molecule for Cellular Damage - A Review
nahid hasan
Molecular Enzymology and Drug Targets, 2016
View PDFchevron_right
Development of matrix metalloproteinase inhibitors in cancer therapy
Michelle Rudek
Hematology/oncology clinics of North America, 2002
View PDFchevron_right
Matrix Metalloproteinase 3 Is Present in the Cell Nucleus and Is Involved in Apoptosis
Arnaud Monvoisin
American Journal of Pathology, 2006
View PDFchevron_right
The Matrix Metalloproteinase Inhibitor Prinomastat Enhances Photodynamic Therapy Responsiveness in a Mouse Tumor Model
David Shalinsky
Cancer Research, 2004
View PDFchevron_right
Variability in melanoma metalloproteinase expression profiling
Orsi Giricz
Journal of Biomolecular Techniques Jbt, 2010
View PDFchevron_right
Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023)
Nour Manoon
Molecules
View PDFchevron_right
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
luis sanchez
International Journal of Developmental Biology, 2004
View PDFchevron_right
Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics
Ferdinando Mannello
Current Cancer Drug Targets, 2005
View PDFchevron_right
Immunohistochemical expression of matrix metalloproteinases in photodamaged skin by photodynamic therapy
Mônica Manela-Azulay
British Journal of Dermatology, 2009
View PDFchevron_right
Natural Bio-Drugs as Matrix Metalloproteinase Inhibitors: New Perspectives on the Horizon?
Ferdinando Mannello
Recent Patents on Anti-Cancer Drug Discovery, 2006
View PDFchevron_right
Matrix metalloproteinase inhibitors: Applications in oncology
D. Yip
Investigational New Drugs, 1999
View PDFchevron_right
Biological Activity and Clinical Implications of the Matrix Metalloproteinases
Holubec Luboš, David Kalfert
View PDFchevron_right
Release of Gelatinase A (Matrix Metalloproteinase 2) Induced by Photolysis of Caged Phosphatidic Acid in HT 1080 Metastatic Fibrosarcoma Cells
Michal Neeman
Journal of Biological Chemistry, 1995
View PDFchevron_right
Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma
Monica Neagu
Biomolecules
View PDFchevron_right
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy
Farbod Darvishian
Journal of Translational Medicine, 2014
View PDFchevron_right
Matrix metalloproteinases: protective roles in cancer
Julie Decock
Journal of cellular and molecular medicine, 2011
View PDFchevron_right
Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages
Carla PALUMBO
International Journal of Oncology, 2012
View PDFchevron_right
Suppression of matrix metalloproteinase-9 by 4-methylumbelliferone
Tomisato Miura
Cell Biology International, 2007
View PDFchevron_right
Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung
Sonam Shah
The Journal of Thoracic and Cardiovascular Surgery, 2010
View PDFchevron_right
Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer
Mads Holten-Andersen
Clinical Cancer Research, 2004
View PDFchevron_right
Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro
Lance Liotta
1996
View PDFchevron_right
Matrix Metalloproteinases and Cancer - Roles in Threat and Therapy
Lalita Yadav
Asian Pacific Journal of Cancer Prevention, 2014
View PDFchevron_right
Triple-Helical Transition State Analogues: A New Class of Selective Matrix Metalloproteinase Inhibitors
Gregg Fields
Journal of the American Chemical Society, 2007
View PDFchevron_right